SCHEMBL6809855

SCHEMBL6809855

NC(=O)CC(N)C(=O)NC(CS)C(=O)NC(CC(N)=O)C(=O)NC(CS)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 2/20 0.47
ACE P12821 1/20 0.44
PTGS1 P23219 2/20 0.40
GSTK1 Q9Y2Q3 1/20 0.40
MME P08473 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40
PTGS2 P35354 1/20 0.40
THPO P40225 1/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PDCD1LG2 Q9BQ51 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
ITGB2 P05107 1/20 0.38
ICAM1 P05362 1/20 0.38
ITGAL P20701 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809859 1.00 ECE1 (0.47) ECE1ACEPTGS1GSTK1MME
SCHEMBL6810742 0.98 ECE1 (0.48) ECE1ACEPTGS1GSTK1MME
SCHEMBL6810737 0.98 ECE1 (0.48) ECE1ACEPTGS1GSTK1MME
SCHEMBL30288037 0.95 ACE (0.49) ECE1ACEPTGS1GSTK1MME
SCHEMBL30287995 0.95 ACE (0.49) ECE1ACEPTGS1GSTK1MME
SCHEMBL16770226 0.94 ACE (0.50) ECE1ACEPTGS1GSTK1MME
SCHEMBL10308197 0.94 ACE (0.50) ECE1ACEPTGS1GSTK1MME
SCHEMBL30390254 0.94 ACE (0.50) ECE1ACEPTGS1GSTK1MME
SCHEMBL30581568 0.92 ECE1 (0.48) ECE1ACEPTGS1GSTK1MME
SCHEMBL7148009 0.92 ECE1 (0.53) ECE1PDCD1LG2CD274ITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040018983-A1 Antifungal compositions ACHILLION PHARMACEUTICALS, INC. 2004-01-29 US claimed
WO-2003055448-A2 ANTIFUNGAL COMPOSITIONS ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-10 WO claimed
US-20040018983-A1 Antifungal compositions ACHILLION PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003055448-A2 ANTIFUNGAL COMPOSITIONS ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040018983-A1 Antifungal compositions CNBP, ERG28, AEBP2 ECE1 3354/4885ACE 3680/4885PTGS1 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.